A Randomized Controlled Trial to Compare the Safety and Efficacy of Tadalafil and Tamsulosin in Relieving Double J Stent Related Symptoms

Table 3

Comparison of mean difference of ureteral stent symptom score at 1st week and 3rd week in three groups.

Characteristics	Mean difference at 1st & 3rd week of three groups			value
	Group A (Tadalafil)	Group B (Tamsulosin)	Group C (placebo)
Urinary symptoms	19.9	20.5	1	<0.0001
Body pain	12.9	3.6	1.8	<0.0001
Sexual health	5.1	1.1	0.8	<0.0001
General health	3.8	2.4	0.7	<0.0001
Work performance	1.8	2	1	<0.0001
Additional problems	0.6	0.2	0.3	0.21

Kruskal-Wallis test; values in the column with different letters indicate significant differences at .